Recombinant Uncharacterized protein Rv2658c/MT2734.1 (Rv2658c, MT2734.1)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can request a specific format when ordering.
Lead Time
Delivery times vary by purchase method and location. Contact your local distributor for details. Proteins are shipped with blue ice packs by default. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-120
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Target Names
Rv2658c, MT2734.1
Target Protein Sequence
MADAVKYVVM CNCDDEPGAL IIAWIDDERP AGGHIQMRSN TRFTETQWGR HIEWKLECRA CRKYAPISEM TAAAILDGFG AKLHELRTST IPDADDPSIA EARHVIPFSA LCLRLSQLGG
Uniprot No.

Q&A

What is Rv2658c/MT2734.1 and why is it significant in tuberculosis research?

Rv2658c/MT2734.1 is an uncharacterized protein from Mycobacterium tuberculosis, the causative agent of tuberculosis. This protein is of interest because:

  • It belongs to the proteome of M. tuberculosis, a pathogen responsible for a significant global health burden

  • Uncharacterized proteins may represent novel drug targets or vaccine candidates

  • Understanding its function could provide insights into M. tuberculosis pathogenesis and survival mechanisms

M. tuberculosis is an obligate aerobic organism with an optimum growth temperature of 37°C, and it cannot grow below 30°C. The bacterium can invade multiple organs, with pulmonary tuberculosis being the most common manifestation. Understanding proteins like Rv2658c may reveal mechanisms that contribute to the bacterium's survival during infection .

How is Rv2658c annotated in different M. tuberculosis reference genomes?

The protein is annotated as:

  • Rv2658c in the H37Rv reference strain

  • MT2734.1 in the CDC1551 strain of M. tuberculosis

This dual nomenclature reflects different annotation systems used for these reference genomes. The "c" in Rv2658c indicates that the gene is encoded on the complementary strand of DNA .

What experimental approaches are most effective for initial characterization of Rv2658c?

For initial characterization of an uncharacterized protein like Rv2658c, implement a multi-faceted approach:

Experimental ApproachMethodologyExpected Outcomes
Bioinformatic analysisSequence homology, domain prediction, structural modelingPreliminary functional predictions
Expression profilingRT-PCR, RNA-seq under various conditions (e.g., starvation, hypoxia)Expression patterns during different physiological states
Subcellular localizationFluorescent protein fusion, immunofluorescence microscopyProtein location within the bacterial cell
Interactome analysisPull-down assays, bacterial two-hybridIdentification of protein-protein interactions
Genetic manipulationGene knockout/knockdown, complementation studiesPhenotypic consequences of gene loss

These approaches should be conducted in parallel to develop a comprehensive understanding of Rv2658c function .

How can researchers address analytical contradictions when studying Rv2658c?

When encountering contradictory results:

  • Apply the Same Analysis Approach (SAA) methodology:

    • Type 1: Apply the same analysis method to variables of the experimental design

    • Type 2: Apply the same analysis to empirical control data

    • Type 3: Apply the same analysis to simulated null data

  • Identify potential sources of error:

    • Mismatch between experimental design and analysis methods

    • Counterbalancing issues in crossover designs

    • Linear decoding of nonlinear effects

  • Implement positive and negative control analyses:

    • Positive controls test if design variables that should influence outcomes yield significant results

    • Negative controls test if variables that should not influence outcomes do not yield significant results

  • Document all conditions systematically:

    • Maintain detailed records of experimental conditions

    • Report both positive and negative findings

    • Distinguish clearly between data and interpretation

What expression systems are optimal for recombinant production of Rv2658c?

Several expression systems can be considered for Rv2658c production:

Expression SystemAdvantagesLimitationsRecommendations
E. coli (BL21, Rosetta)Fast growth, high yield, established protocolsMay form inclusion bodies, lacks mycobacterial post-translational modificationsUse codon-optimized constructs; try low-temperature induction
M. smegmatisMycobacterial host, similar cell envelope, better protein foldingSlower growth than E. coli, lower yieldsUseful if E. coli expression fails; provides more native-like protein
Yeast systemsEukaryotic post-translational modificationsMay not recognize mycobacterial signalsConsider for secreted or glycosylated proteins
Cell-free systemsAvoids toxicity issues, rapidExpensive, limited scaleGood for initial screening or toxic proteins

According to available information, E. coli is commonly used for initial attempts at expressing mycobacterial proteins, with sources including E. coli, yeast, baculovirus, or mammalian cell systems .

What purification challenges are specific to Rv2658c and how can they be addressed?

While specific challenges for Rv2658c are not detailed in the available literature, mycobacterial proteins often present the following purification challenges:

  • Solubility issues:

    • Use solubility-enhancing tags (MBP, SUMO, Trx)

    • Optimize buffer conditions (pH, salt concentration, additives)

    • Consider mild detergents for membrane-associated proteins

  • Stability concerns:

    • Include stabilizing agents (glycerol, arginine, trehalose)

    • Maintain reducing conditions if cysteine residues are present

    • Consider on-column refolding protocols

  • Purity verification:

    • Employ SDS-PAGE and western blotting for identity confirmation

    • Use mass spectrometry for molecular weight verification

    • Apply dynamic light scattering to assess aggregation state

For recombinant Rv2658c specifically, sources indicate it can be produced from E. coli or alternative expression systems, suggesting that standard affinity purification approaches may be applicable .

How can transcriptomic data inform our understanding of Rv2658c function?

Transcriptomic analysis can provide valuable insights into Rv2658c function:

  • Expression correlation analysis:

    • Identify genes co-expressed with Rv2658c

    • Map these to known functional pathways

    • Infer potential involvement in specific cellular processes

  • Condition-dependent expression:

    • Analyze expression during:

      • In vitro stress conditions (starvation, hypoxia, acid stress)

      • Macrophage infection

      • Animal model infection stages

    • Compare to expression patterns of genes with known functions

  • Regulatory network analysis:

    • Identify potential transcription factors regulating Rv2658c

    • Map the gene to known regulons in M. tuberculosis

Drawing from studies of other M. tuberculosis genes, researchers should be cautious about transcript orientation and potential small RNAs. For example, the study of Rv2660c revealed that the upregulated transcript during starvation was actually a small RNA encoded on the opposite strand, not the protein-coding gene as initially thought .

What approaches can determine if Rv2658c plays a role in M. tuberculosis drug resistance?

To investigate potential involvement in drug resistance:

Experimental ApproachMethodologyExpected Outcomes
Expression analysisqRT-PCR or RNA-seq comparing drug-resistant vs. sensitive strainsDifferential expression suggesting role in resistance
Genetic modificationOverexpression in sensitive strains; knockout in resistant strainsChanges in minimum inhibitory concentrations (MICs)
Drug susceptibility testingBroth microdilution or disk diffusion assays with mutant strainsAltered susceptibility profiles
Evolution experimentsSerial passage under drug selectionEmergence of mutations in Rv2658c
Biochemical assaysIn vitro drug modification or binding assaysDirect interaction with antimicrobials

The increasing prevalence of multi-resistant strains of M. tuberculosis globally highlights the importance of understanding all potential resistance mechanisms, including uncharacterized proteins that might contribute to resistance .

What computational methods can predict the structure of Rv2658c in the absence of experimental data?

In the absence of experimental structures, several computational approaches can predict Rv2658c structure:

  • Homology modeling:

    • Identify templates through sensitive sequence searches (HHpred, HMMER)

    • Generate models using programs like MODELLER or SWISS-MODEL

    • Validate using energy minimization and Ramachandran plot analysis

  • Ab initio and deep learning methods:

    • AlphaFold2 for high-confidence predictions

    • RoseTTAFold as an alternative approach

    • I-TASSER for threading-based modeling

  • Integrative modeling:

    • Combine predictions with sparse experimental data

    • Use coevolutionary information to predict contacts

    • Apply molecular dynamics simulations for refinement

  • Functional site prediction:

    • Identify conserved residues through multiple sequence alignment

    • Predict binding pockets using CASTp or COACH

    • Map conservation onto the structural model using ConSurf

These approaches can provide a starting point for structure-function hypotheses that can be tested experimentally.

What experimental structures would provide the most informative comparisons for Rv2658c?

When analyzing predicted or experimental structures of Rv2658c, comparing to these structural classes would be most informative:

  • Structures of other M. tuberculosis proteins with similar predicted secondary structure profiles

  • Proteins involved in mycobacterial cell wall synthesis or modification

  • Structures of stress response proteins from related organisms

  • Proteins involved in dormancy or persistence mechanisms

  • Structures of proteins with similar domain architectures, even from distant organisms

How might Rv2658c contribute to M. tuberculosis survival during infection?

Several potential roles for Rv2658c in M. tuberculosis pathogenesis can be hypothesized:

  • Stress response:

    • Adaptation to nutrient limitation during infection

    • Response to oxidative or nitrosative stress in macrophages

    • Adaptation to hypoxic conditions in granulomas

  • Cell wall modulation:

    • Contribution to cell envelope integrity

    • Modification of cell surface to evade immune recognition

    • Alteration of permeability to antibiotics or host factors

  • Metabolic adaptation:

    • Role in alternative metabolic pathways during persistence

    • Contribution to utilization of host-derived nutrients

    • Involvement in energy conservation during dormancy

  • Regulatory functions:

    • Potential role as a transcriptional or post-transcriptional regulator

    • Signal transduction during host-pathogen interaction

M. tuberculosis is known to adapt to various stress conditions during infection, including nutrient starvation, which has been shown to induce expression of certain genes. Studies of similar uncharacterized proteins have revealed important roles in survival and persistence .

What is known about Rv2658c immunogenicity and potential as a vaccine component?

While specific information about Rv2658c immunogenicity is limited in the provided sources, assessment as a vaccine candidate would involve:

  • Antigenicity evaluation:

    • In silico epitope prediction

    • T-cell stimulation assays with synthetic peptides

    • B-cell epitope mapping

  • Conservation analysis:

    • Sequence conservation across clinical isolates

    • Presence in BCG and other vaccine strains

    • Absence in environmental mycobacteria

  • Safety assessment:

    • Homology to human proteins

    • Potential molecular mimicry concerns

    • Cross-reactivity with commensal microbiota

  • Immunological properties:

    • Ability to induce Th1/Th17 responses

    • Memory T-cell generation

    • Protective efficacy in animal models

Recombinant proteins from M. tuberculosis, including uncharacterized proteins like Rv2658c, are being investigated for vaccine development, though their use is currently limited to research purposes as noted in source materials .

How can CRISPR-based approaches advance our understanding of Rv2658c function?

CRISPR technologies offer powerful tools for studying Rv2658c:

  • CRISPRi (interference) applications:

    • Tunable knockdown of Rv2658c expression

    • Temporal control of repression to study essentiality at different growth phases

    • Multiplexed targeting to study genetic interactions

  • CRISPR-Cas9 genome editing:

    • Clean deletion or modification of Rv2658c

    • Introduction of point mutations to test specific residues

    • Insertion of reporter tags at the endogenous locus

  • CRISPRa (activation) approaches:

    • Overexpression of Rv2658c from its native locus

    • Study of dose-dependent phenotypes

    • Combination with stress conditions to identify synthetic phenotypes

  • CRISPR-based screening:

    • Library-scale assessment of conditions where Rv2658c becomes essential

    • Identification of genetic interactions through double-knockdown screens

These approaches overcome many limitations of traditional genetic manipulation in slow-growing mycobacteria.

What protein-protein interaction methods are most suitable for studying Rv2658c in its native context?

To study Rv2658c interactions in a near-native context:

MethodAdvantagesLimitationsKey Considerations
Proximity-dependent labeling (BioID, APEX)Detects transient interactions; works in native conditionsRequires genetic modification; potential false positivesExpression level control; appropriate controls
Chemical crosslinking with MSCaptures direct interactions; can work with endogenous proteinsComplex data analysis; potential artifactsCrosslinker selection; fragmentation conditions
Co-immunoprecipitationEstablished technique; can detect stable complexesRequires specific antibodies; may disrupt weak interactionsBuffer optimization; confirmation with reciprocal pulldowns
Bacterial two-hybridGenetic screening approach; high-throughputArtificial environment; potential false positivesAppropriate controls; validation with orthogonal methods
Split-protein complementationCan detect interactions in living cellsPotential steric hindrance; false negativesOptimization of linker length; multiple tag orientations

For a protein like Rv2658c with unknown function, employing multiple complementary methods is recommended to build confidence in the identified interactions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.